Fresenius

Fresenius, a prominent German healthcare company headquartered in Europe, is actively engaged in shaping a more sustainable economy and society through its participation in the econsense sustainability network. This initiative connects 40 German companies focused on practical, cross-industry exchange to advance sustainability management. Sustainability is a core tenet of Fresenius Medical Care's mission and vision, integrated into its corporate strategy to create enduring economic, ecological, and social value. The company prioritizes providing high-quality products and services to patients while actively conserving the environment. Fresenius operates with a substantial workforce, ranging from 1,000-5,000 employees, contributing to its extensive operations and market presence. Meet Fresenius's team to understand the leadership driving these initiatives. The company has demonstrated consistent growth, with its main shareholder assembly noting a continued upward trajectory even amidst global challenges like the COVID-19 pandemic. This resilience is reflected in its financial performance, with dividends increasing for the 28th consecutive time. Fresenius Medical Care has reaffirmed its growth targets for 2025, underscoring its strategic focus and operational capabilities. Despite the pandemic's significant impact, the company achieved its 2020 objectives and provided an outlook for 2021, expecting healthy revenue growth and stable earnings development. Furthermore, Fresenius is addressing critical industry issues, such as the lag in medical digitalization in Germany, as highlighted by a Fresenius and Allensbach study, indicating a commitment to innovation and future healthcare solutions.